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I. Background Information 
I-1. Introduction 
Hematopoietic stem and progenitor cells (HSPCs) give rise to all other blood cell lineages1.  Like 
other stem cells, HSPCs are characterized by their ability to self-renew and differentiate, thereby 
sustaining the entire blood system of a vertebrate organism by supplying the body with >100 
billion blood cells daily. Over a lifetime, this process occurs in two waves. The first, or 
“primitive,” wave occurs in embryonic development and supplies predominantly erythrocytes 
and macrophages.  The second, “definitive,” wave begins soon after and produces true HSCs, 
which are responsible for producing blood cells for the remainder of the life of the animal.2  A 
delicate balance between quiescence, self-renewal, and differentiation must be maintained by 
controlling the number of HSPCs undergoing the cell cycle at any given time.3 One important 
factor of this maintenance is cellular cross-talk between these HSPCs and their 
microenvironment.4 
 
In vertebrates, definitive HSCs begin their life 
in the aorta-gonad-mesonephros region during 
very early embryonic development. From there, 
they migrate to the fetal liver where they 
remain until birth. From the liver, they can 
migrate to one of several destinations, but 
eventually end up residing in the bone 
marrow5,6 (Figure 1). Wherever the HSPCs Figure 1. Migration of HSPC in mammals 
throughout development5 
settle, they cluster into small colonies, which, along 
with their microenvironment, are termed the “stem cell 
niche.”4 When an HSPC arrives at certain niches, 
namely in the fetal liver for mammals, a phenomenon is 
observed whereby a group of endothelial cells will 
remodel around the HSPC and envelop it (Figure 2). 
This remodeling process, also known as “cuddling”, has 
been shown to be conserved throughout evolution, as it 
was seen in both murine, zebrafish, and drosophila 
models7,8. Interactions within the niche were thought to 
be crucial modulators of stem cell fate, as it had been 
observed that premature removal from the niche results in loss of capability of the HSPC to self-
renew9. However, the specific mechanisms and pathways that are involved in this interaction are 
not well understood, and therefore provide an opportunity to explore and attempt to further 
elaborate how stem cell fate is determined. 
 
I-2. Zebrafish as a Model for HSPC development 
The zebrafish, Danio rerio, is an effective model for vertebrate hematopoiesis because 
zebrafish hematopoiesis also occurs in distinct waves, involves cells with similar properties and 
relies on similar developmental programs when compared to mammals.11 The use of established 
transparent lines also allows for large scale, in-vivo, chemical and biological screens. Their 
transparency also allows for live real-time imaging and tracking of HSPCs, which aids the study 
of cell migration and differentiation.12 
Figure 2. Niche cuddling in the zebrafish 
caudal hematopoietic tissue (CHT)15 
In zebrafish, hematopoiesis begins in the mesoderm. During early development, around 
48 hours post-fertilization (hpf), HSPCs move to inhabit what is known as the caudal 
hematopoietic tissue (CHT), after which (around 96-110 hpf) they finally settle in the kidney 
marrow, which functionally equivalent to the bone marrow niche in mammals (Figure 3).12, 13 
The time spent in the CHT is of particular interest as chemical signals from the CHT affect stem 
cells’ activity in terms of both self-renewal and differentiation14. Moreover, the same niche 
cuddling that is observed in mammalian fetal liver can be seen here in the CHT (Figure 2).7,15 
 
II. Effects of Ibrutinib on CHT Residence of HSPCs 
II-1. Background Information 
Figure 3. HSPC destinations throughout early development in Zebrafish13 
Ibrutinib is a known Bruton’s Tyrosine Kinase (BTK) inhibitor that is commonly used to treat 
various cancers including multiple types of B-cell malignancies such as chronic lymphocytic 
leukemia and mantle cell lymphoma.16 BTK has 
recently been shown to play a role as a signaling 
intermediate  in a number of pathways, including 
NF-κB and MAPK signaling pathways, which have 
known roles in HSC biology (Figure 4).17 However, 
the effects of ibrutinib on HSCs and the 
hematopoietic stem cell niche are completely 
unknown. 
 
II-2 Primary Aim 
Does the inhibition of BTK by Ibrutinib affect HSPC 
residence in the CHT? 
Since ibrutinib interrupts several signaling pathways important for HSC development, we 
hypothesized that ibrutinib treatment would alter the behavior of HSCs within the niche.  
 
II-3. Method and Project Schematic 
Viability of Ibrutinib-treated zebrafish embryos at various concentrations. 
A dose-escalation toxicity study was performed to determine the maximum-tolerated dose for 
embryonic zebrafish.  Dry ibrutinib was dissolved in enough DMSO to form a 5mM stock 
solution. The stock solution was then further dissolved in E3 solution (the medium in which 
young zebrafish develop) to final concentrations of 0.5μM, 1.5μM, 5.0μM, and 15.0μM, along 
Figure 4. A sample of the pathways in 
which BTK is involved17 
with a control with an equal concentration of DMSO (1:1000 DMSO:E3). A stable mutant 
zebrafish line lacking iridophores and melanophores (casper) was in-crossed. Embryos were 
dechorionated at 36 hpf and placed into one of the four ibrutinib solutions at 48 hpf. At 72 hpf, 
the fish were treated with tricaine sedative, placed individually in the wells of a 96-well plate and 
observed by brightfield microscopy. While the embryos in the 0.5µM, 1.5µM, and 5.0µM 
solutions showed no significant difference in viability and development compared to the DMSO 
control, the embryos in the 15μM solution showed notably impaired angiogenesis, irregular 
morphology (Figure 5) and decreased viability (data not shown). Therefore, it was decided that 
future experiments would proceed with a concentration of 5.0μM. 
 
Effect of Ibrutinib on HSPC residence in the CHT 
To analyze the effects of ibrutinib on HSCs within the CHT, a stable transgenic reporter line 
(Tg(Runx1:GFP)) was used. The Runx1 enhancer region is derived from an intron of the murine 
Runx1 gene but drives expression specifically in  zebrafish HSPCs.7,20 Therefore, transgenic 
embryos that contain the promoter linked to a fluorescent reporter will have specifically their 
HSPCs illuminated, allowing in-vivo tracking and counting of the cells at any given time. An in-
cross was done from this line and the embryos were collected and dechorionated in the manner 
previously stated. At 48 hpf, the remaining viable embryos were divided evenly and placed into 
either the 5.0μM Ibrutinib solution, or a control solution with an equal concentration of DMSO 
(1:1000 DMSO:E3). A total of 86 total fish were treated with tricaine, separated into individual 
wells of a 96-well plate and imaged (39 treated and 47 control) with a Keyence BZX-710 
fluorescence confocal microscope and processed in ImajeJ. HSPCs were enumerated and a lower 
average number of cells were observed in fish treated with Ibrutinib. The experiment was  
Figure 5. Zebrafish embryos at 72 hpf treated with a 15 μM (upper) vs DMSO control (lower). Irregular 
vascularity and a curved spine can be seen in the fish from the 15μM solution. A zoomed in picture below 
highlights the irregular vascularity of the treated fish 
       
repeated with a different reporter line that contained an mcherry transgene instead of GFP. This 
reporter line is significantly brighter and has broader expression making it easier to identify a 
decrease in HSPCs resulting from ibrutinib treatment.  The new clutch was similarly 
dechorionated, divided and treated with one solution or the other.  At 72 hpf, 51 embryos (26 
treated and 25 control) were placed in agarose gel in the wells of a 6-well plate in order to ensure 
consistent positioning of the fish relative to the microscope. Images were acquired on a Keyence 
BZX-710 fluorescence confocal microscope and processed in ImageJ.  Fluorescence, size and 
roundness thresholds threshold were applied and tuned to identify the expected number of 
HSPCs in control animals (8-10).  This required manual curation to include only HSPCs located 
within the CHT. The images were then blinded for Donn Calkins, the Ph.D. candidate that 
supervises me, to recount and analyze. For analysis, a two-factor T-test was done with each 
count treated as an individual argument, using an assumption of unequal variances. 
 
II-4. Data 
Ibrutinib-treated embryos showed significantly fewer HSPCs in the CHT compared to control 
embryos in both the Tg(runx1:GFP) line (6.3±3.0 vs 8.1±3.1, p=0.0015) and in the 
Tg(runx1:2amcherry) line (6.6±3.1 vs 9.4±3.3, p=0.016). The blinded recount of the 2amcherry 
transgenic line returned similar results (5.3±2.9 vs 8.3±3.6, p=0.0022). 
  
 Figure 6. Images of a runx1:GFP ibrutinib-treated(top green) fish and a corresponding DMSO control (bottom 
green) along with images of a runx1:2amcherry ibrutinib-treated (top red) fish with a corresponding control 
(bottom red). The CHT can be seen as a strip of elevated fluorescence near the bottom of each fish. 
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II-5 Conclusions and Next Steps 
These experiments suggest that ibrutinib treatment reduces HSPC colonization of the CHT.  
Future studies will aim to uncover the cellular and molecular mechanisms underlying this 
observation.  BTK has been shown to be a regulator of Wnt/Beta-Catenin signaling21 which has 
an important role the decision between HSPC quiescence and expansion22.  Likewise, BTK is an 
important intermediate in MAPK and AKT signaling and in direct regulation of NF-kB activity, 
all of which have roles in HSPC-niche interactions23,17. An important consideration is whether or 
not ibrutinib will affect the time HSPCs spend cuddling in the niche. We hypothesize that time 
Figure 7. Average HSPC per fish at 72 hpf in each group, carried out over 4 separate clutches. In each 
clutch, the fish showed more HSPCs on average (left) along with a graph of the re-count, provided by Donn 
Calkins (right) 
0
1
2
3
4
5
6
7
8
9
10
11
12
13
runx1:GFP runx1:2amcherry
A
ve
ra
ge
 H
SP
C
s 
p
e
r 
Fi
sh
runx1 reporter expression at 72 hpf in 
Ibrutinib-treated fish vs control
Ibrutinib-treated fish DMSO control fish
spent cuddling in CHT will be reduced by ibrutinib treatment, and future experiments will assess 
this. 
 
III. Effect of monocyte/macrophage-produced interleukin 8 on niche cuddling 
III-1. Background information. 
Interleukin 8 (IL-8, cxcl8) is a chemokine that has been shown to be involved in a plethora of 
processes throughout an organism’s lifetime, from angiogenesis25 to immune response26. 
Previous work done by Dr. Blaser has shown that cxcl8 promotes niche remodeling via the cxcr1 
receptor. This was done by first identifying differential expression between HSPCs in the CHT 
niche and HSPCs in the adult kidney marrow. Candidate genes were then tested via genetic 
manipulation to see if overexpression of candidate genes led to a corresponding increase in niche 
colonization. This proved true for both cxcl8 and its receptor cxcr1. This association was further 
supported by gain-of-function and loss-of-function experiments involving the cxcr1 receptor.27 
More recently, Blaser Lab observed that monocytes are the major producer of cxcl8 among 
human peripheral blood mononuclear cells and that brief (4-hour) treatment with ibrutinib 
rapidly downregulated cxcl8 expression. This led us to hypothesize that monocyte/macrophage-
derived cxcl8 might be important for HSPC colonization of the CHT. 
 
III-2 Primary Aim 
Does upregulating monocyte production of IL-8 have an effect on niche cuddling? If so, is there 
a notable difference between the effect of inducing monocyte -produced IL-8 and upregulating 
IL-8 produced in endothelial cells? 
The next aim of the project was to develop a transgenic zebrafish line with 
monocytes/macrophages that constitutively express cxcl8 at high levels. 
 
 
III-3 Method and Project Schematic 
Generation of the mpeg1.1:IL-8:2amcherry plasmid 
Zebrafish mpeg1.1 is orthologous to human MPEG1, which is expressed by monocytes and 
macrophages and forms part of the pore-forming attack complex used in host defense31. A 
Gateway reaction was done in which a 5’ entry vector containing the mpeg1.1 enhancer/promoter 
region (p5e mpeg1.1), a middle entry vector containing the zebrafish cxcl8 ORF and a 3’ entry 
vector containing the 2amcherry reporter construct, were all added to an destination vector 
containing a cyraa:yfp backbone. The reaction was carried out according to the protocols 
established by ThermoFisher32 resulting in a Tol2-flanked mpeg1.1:cxcl8:2amcherry expression 
cassette on the cryaa:yfp backbone vector. The final 9.1kb expression vector was then 
transformed into competent bacterial cells, plated on an ampicillin agar and incubated overnight. 
Colonies were harvested and placed into individual tubes of LB broth + ampicillin and incubated 
overnight once more. The DNA was then extracted from each colony. Some was saved for 
injection, the rest digested with BamHI and PvuI and run on a gel to ensure that the fragment 
sizes matched those predicted based on sequence (Figure 9). 
 Figure 9. Gateway reaction illustrations Figure 9. Overview of the Gateway reaction 
Figure 10. Electrophoresis gel of BamHI+PvuI digested mpeg1.1:IL8:2amcherry palsmids. Lanes 1-10 
contained digested plasmid from individual colonies, while lane 12 contained undigested plasmid 
from the same colony as lane 2 (left) along with the expected fragment lengths based on predicted 
sequence (right). 
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Tol2-mediated transgenesis of mpeg1.1:IL-8:2amcherry 
The plasmid was then mixed with along with mRNA that encodes for the Tol2 transposon, and 
red dye for injection visibility. The mix was then injected into a casper zebrafish embryos at the 
single-cell stage.  The fish were cleaned with ovadine, dechorionated, and incubated until 72 hpf, 
at which point they were screened to check for proper expression (Figure 12). Those with 
appropriate 
expression were 
placed in a tank to 
develop until they 
were able to produce 
an F1 generation, 
which is roughly a 3-
month period. These 
animals are currently 
growing in the aquatic 
facility. 
 
III-4 Data 
A total of 9 fish showed significant mpeg1.1-mediated fluorescence and were selected for further 
experiments (Figure 12) 
 
Figure 11. Overview of Tol2-mediated transgenesis in zebrafish33 
 III-5 Discussion 
The next step in this project is to outcross F0 animals to identify those with germline 
transmission and then to outcross F1 animals to identify founders with appropriate expression 
and Mendelian inheritance.  The expression pattern will be validated in F2 animals by crossing to 
the established mpeg1.1:GFP line. 
 
Once an mpeg:cxcl8-2a-mcherry line is established, a useful first experiment to test the effect of 
monocyte-produced IL-8 would be to cross an mpeg1.1:IL-8:2amcherry+/- fish to a 
runx:GFP+/+ fish. The offspring could be screened at 48 hpf for red monocyte/macrophage 
expression and split into positive and negative groups. The clutch, now the F2 generation can 
then be imaged at 72 hpf and the green HSPC count can be compared between the mpeg1.1:IL-
8:2amcherry+ fish and the mpeg1.1:IL-8:2amcherry- control fish.  
 
Figure 12. mpeg1.1:IL8:2amcherry injected fish showing monocyte/macrophage fluorescence in the CHT () vs 
an uninjected control from the same clutch (bottom) 
IV. General conclusion 
IV-1 Relevance and applications of the characterization of the HSPC niche. 
These experiments have relevance and impact for patients undergoing hematopoietic stem cell 
transplantation, particularly those with myelofibrosis where the normal marrow 
microenvironment has been replaced by collagen.  In addition, characterizing the stem cell niche 
allows us to better understand the implications of when it goes wrong, which we can see in 
diseases such as hematological malignancies.34 Any progress towards a better understanding of 
what causes these complex issues helps in attempts to treat or alleviate them. Eventually, a 
thorough understanding of the interactions between the HSPCs and their niche may allow for 
transplant-ready HSPCs grown entirely in-vitro from induced pluripotent stem (IPS) cells.36  
 
IV-2 Discussion of Results 
The work presented here provides starting point for further mechanistic studies aiming to 
understand how monocytes, or other cells, know when and where to produce cxcl8 in order to 
facilitate HSPC interactions with the niche.  These studies will be performed by other members 
of the Blaser Lab in the zebrafish and in in vitro models of the niche when the current research 
hiatus has ended.  I have learned a great deal from my time in the Blaser Lab, and will carry that 
knowledge along with me as I continue my career in research. 
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